Alzheimer's disease treatments, such as Aricept, Reminyl and Exelon, appear to be ineffective in delaying the progression from mild cognitive impairment to dementia, Italian scientists report. The findings contradict a popular thought among experts and patients groups that anti-cholinesterase drugs should be made available to MCI patients.

Full Story:

Related Summaries